New Biopolis probiotic mix helps reduce topical steroid use by atopic dermatitis patients

3b5b149a-05ee-4d16-bcb4-596e35dd3d5darticleimage.jpg

07 Dec 2017 --- Biopolis, majority owned by agricultural processor and food ingredient provider Archer Daniels Midland Company (ADM), has introduced a new probiotic mix designed to reduce the need for topical steroid use by Atopic Dermatitis (AD) patients. The clinical research recently published in JAMA Dermatology, an international peer-reviewed general medical journal, shows the benefits of consuming a mix of probiotics in reducing the need for topical steroids by AD patients.

Atopic Dermatitis (AD) is an inflammatory skin disease that affects 20 percent of children worldwide. It’s the most common form of eczema and typically involves symptoms such as redness, dry skin and an intense itch.

The disease of AD can significantly reduce the quality of life for patients and their families. Furthermore, children suffering from AD have an increased risk of other atopic disorders, including asthma, allergic rhinitis and chronic sinusitis. Steroids are the most commonly prescribed medication for the treatment of AD and often have undesirable side effects.

Benefits of probiotics mix
The research was conducted by Dr. Vicente Navarro-López and coworkers and involved 50 AD patients aged 4 to 17. The study involved a probiotic mixture in the form of a bulk powder that was made from three different Biopolis proprietary culture strains.

The culture mix was provided to the patients as a supplement, in capsule form, taken orally. It was designed so that the probiotics were administered together with topical corticosteroids, given the supplementary nature of the probiotic treatment. The study was randomized, double blinded and placebo controlled.

In summarizing the outcomes of the 12-week study, the researchers stated: “The mixture of probiotics was effective in reducing SCORAD (Scoring Atopic Dermatitis) index and reducing the use of topical steroids in patients with moderate AD.”

“These results illustrate the tremendous potential of probiotics used in this study to really make a difference to the quality of life for these young AD patients,” says Daniel Ramón Vidal, VP R&D, ADM Bioactives. “This study was directed at children with moderate Atopic dermatitis, and given the success and positive results we’ve seen, we are now planning future studies amongst children with both mild and severe Atopic dermatitis, as well as in adults with similar symptoms to continue to evaluate the potential of this mixture.”

The potential of probiotics to treat allergies was also recently reinforced by a study suggesting that modifying the gut microbiome may eventually prevent asthma in infant boys. The wider benefits of a healthy microbiome were also suggested by study results showing that the “ridiculously healthy” had the same microbiome as healthy 30-year-olds. 

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Maple water: One to watch amid plant-based waters surge

15 Aug 2018 --- Plant-based waters are rising as a share of soft drink launches, with Innova Market Insights reporting a 25 percent CAGR in this emerging area of NPD between 2012 and 2017, compared with a 7 percent CAGR for the soft drinks category as a whole. Despite coconut water clearly leading the plant-based hydration category, 2017 saw 28 percent of the category launches from new plant-based waters, with maple water among the beverages within this category expansion, albeit from a small base.

Health & Nutrition News

Baobab resurgence? Things are looking up for the “upside down” tree

14 Aug 2018 --- The baobab superfruit has been enjoying an NPD resurgence, boosted by renewed interest in the digestive health and low GI space, as well its strong potential for use in the sports nutrition market. The superfood – which is touted as offering low GI appeal, a high dietary fiber content and for being rich in vitamin C – has seen annual growth of 53 percent, according to Innova Market Insights data. Speaking to NutritionInsight, Henry Johnson, baobab specialist at EcoProducts, details the growing array of applications for the superfood, as well as the economic ripening of the environment for market growth for baobab.

Health & Nutrition News

Microbe colonization study could inspire better probiotics, claim researchers

13 Aug 2018 --- A novel approach to identify the genes that may be important to help microbes live successfully in the human gut has been identified by a study published in PLOS Computational Biology. The approach utilizes a technique called phylogenetic linear modeling, which has often been used in ecology, but rarely in genomics. The researchers hope that the findings could be important for the development of new therapies to maintain or improve gut health, such as the design of better probiotics.

Health & Nutrition News

Weekly roundup: Lycored awarded for campaign, Support for probiotics in countering depression

10 Aug 2018 --- This week, Lycored was awarded for their innovative #rethinkbeautiful campaign and Good in Bloom initiative, while a new study supports the hypothesis that the modification of microbial ecology in human gut by supplementing probiotics may be an alternative strategy to ameliorate or prevent depression.

Health & Nutrition News

Montmorency tart cherries may help enhance gut health, finds small scale study

07 Aug 2018 --- Montmorency tart cherries may play a role in improving gut health, suggests a first-of-its-kind human trial of nine adults combined with a parallel laboratory study published in the Journal of Nutritional Biochemistry. An international team of scientists found that Montmorency tart cherries helped to positively impact the gut microbiome – a collection of trillions of bacteria and other microbes that live in the intestinal tract. The study has been highlighted by the trade association The Cherry Marketing Institute.

More Articles
URL : http://www.nutritioninsight.com:80/news/new-biopolis-probiotic-mix-helps-reduce-topical-steroid-use-by-atopic-dermatitis-patients.html